| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/10/1999 | WO1999044594A1 Fat emulsions for inhalational administration |
| 09/10/1999 | WO1999044584A1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/10/1999 | WO1999033967A3 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 09/10/1999 | WO1999033866A3 Antivirally active oligopeptide isolated from royal jelly |
| 09/10/1999 | WO1999033486A9 Composition and method for dermal and transdermal administration of a cytokine |
| 09/10/1999 | WO1999033481A3 Process using the growth factor igf-i in the manufacture of compositions that are useful in the treatment of cerebellar ataxia |
| 09/10/1999 | WO1999032644A3 Prostate cancer gene |
| 09/10/1999 | WO1999032622A3 Semaphorin zsmf-3 |
| 09/10/1999 | WO1999032514A3 Sag: sensitive to apoptosis gene |
| 09/10/1999 | WO1999028466A9 Compositions and methods of use of het |
| 09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/10/1999 | WO1999027949A9 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE |
| 09/10/1999 | WO1999027948A3 Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response |
| 09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
| 09/10/1999 | WO1999025819A3 Antisense oligonucleotides against tenascin for treating vitiligo |
| 09/10/1999 | WO1999021992A3 Nucleic acid molecules encoding a glutamate receptor |
| 09/10/1999 | WO1999020756A3 Human toll homologues |
| 09/10/1999 | WO1999020644A9 Secreted proteins and polynucleotides encoding them |
| 09/10/1999 | WO1999010487A9 Novel transcriptional regulators and uses therefor |
| 09/10/1999 | WO1998053839A3 Anti-cancer products for treating cystic fibrosis |
| 09/10/1999 | CA2326408A1 Epitope peptides immunogenic against streptococcus pneumoniae |
| 09/10/1999 | CA2322838A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 09/10/1999 | CA2322785A1 Treatment of fibromyalgia with low interferon doses |
| 09/10/1999 | CA2322731A1 Lectomedin materials and methods |
| 09/10/1999 | CA2322712A1 Method for activating natural killer (nk) cells |
| 09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | CA2322665A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | CA2322664A1 Enhanced prodrug activation |
| 09/10/1999 | CA2322621A1 V-like domain binding molecules |
| 09/10/1999 | CA2322592A1 Use of a peptide or antibody in the manufacture of a medicament for treating an erbb protein medicated tumor in combination with irradiation |
| 09/10/1999 | CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | CA2322381A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | CA2322337A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | CA2322294A1 Il-12 enhancement of immune responses to t-independent antigens |
| 09/10/1999 | CA2322051A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphthyl)ethyl)amide |
| 09/10/1999 | CA2321996A1 Chimeric proteins with cell-targeting specificity and apoptosis-inducingactivities |
| 09/10/1999 | CA2321270A1 Novel calpain and dna encoding the same |
| 09/10/1999 | CA2321171A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | CA2265069A1 Oral immunity enhancing agent |
| 09/10/1999 | CA2249661A1 Novel compounds |
| 09/10/1999 | CA2249041A1 Novel compounds |
| 09/09/1999 | DE19808192A1 Diisopropylfluorophosphatase sowie deren Verwendung und Herstellung Diisopropyl fluorophosphatase and their use and production |
| 09/09/1999 | DE19802569A1 New fragment of the lethal toxin from Clostridium bacterium, useful for treating cancer |
| 09/08/1999 | EP0940468A1 Humanized antibody variable domain |
| 09/08/1999 | EP0940467A1 Promoters for swine complement inhibitors |
| 09/08/1999 | EP0940400A1 Novel heterocyclic amide compounds and medicinal uses thereof |
| 09/08/1999 | EP0939835A1 Compositions and methods for treating viral infections |
| 09/08/1999 | EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 09/08/1999 | EP0939829A1 Methods of modulating melanin synthesis |
| 09/08/1999 | EP0939828A1 Herpesvirus saimiri as viral vector |
| 09/08/1999 | EP0939826A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 09/08/1999 | EP0939824A1 Reagents and methods useful for detecting diseases of the breast |
| 09/08/1999 | EP0939823A1 Genes encoding telomerase proteins |
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939820A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof |
| 09/08/1999 | EP0939819A1 Mini-e1a genes and gene products |
| 09/08/1999 | EP0939818A1 Recombinant toxin fragments |
| 09/08/1999 | EP0939817A2 High-affinity interleukin-4 muteins |
| 09/08/1999 | EP0939816A1 Circularly permuted erythropoietin receptor agonists |
| 09/08/1999 | EP0939815A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION |
| 09/08/1999 | EP0939814A1 Fringe proteins and notch signalling |
| 09/08/1999 | EP0939813A1 Breast carcinoma-associated gene |
| 09/08/1999 | EP0939812A2 Novel human macrophage antigen |
| 09/08/1999 | EP0939809A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939806A1 Fanconi gene 1 |
| 09/08/1999 | EP0939805A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939804A1 NEUTROKINE alpha |
| 09/08/1999 | EP0939803A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 09/08/1999 | EP0939800A2 HELICOBACTER ANTIGEN (gamma-GLUTAMYLTRANSFERASE) AND SEQUENCES ENCODING THE SAME |
| 09/08/1999 | EP0939796A1 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10 |
| 09/08/1999 | EP0939770A1 Receptor specific brain natriuretic peptide (bnp) |
| 09/08/1999 | EP0939767A1 Modified factor viii |
| 09/08/1999 | EP0939766A2 Synthesis of soluble beta-sheet forming peptides |
| 09/08/1999 | EP0939765A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 09/08/1999 | EP0939761A1 Salmonella secreted proteins and uses thereof |
| 09/08/1999 | EP0939758A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/08/1999 | EP0939656A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 09/08/1999 | EP0939655A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 09/08/1999 | EP0939652A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
| 09/08/1999 | EP0939651A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes |
| 09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/08/1999 | EP0939644A1 Enhanced stimulation of erythropoiesis |
| 09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0939621A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
| 09/08/1999 | EP0939589A2 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
| 09/08/1999 | EP0871463A4 Regulation of eating behavior |
| 09/08/1999 | EP0738329A4 Hybrid cytokines |
| 09/08/1999 | EP0722460B1 Derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 09/08/1999 | EP0671943B1 Use of enzymes, especially bromelain, in the treatment of non-infectious diarrhoea |
| 09/08/1999 | EP0669834B1 Use of topically applied factor xiii for inhibiting hemorrhage |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | EP0583352B1 hGPIIb FRAGMENTS AND THEIR USE IN $i(IN VITRO) METHODS FOR DETERMINING $i(IN VIVO) THROMBOTIC EVENTS |
| 09/08/1999 | CN1228028A Use of histamine for therapeutic purposes |